Click
here to close Hello! We notice that
you are using Internet Explorer, which is not supported by Echinobase
and may cause the site to display incorrectly. We suggest using a
current version of Chrome,
FireFox,
or Safari.
Biochem J
2006 Dec 15;4003:551-61. doi: 10.1042/BJ20060212.
Show Gene links
Show Anatomy links
Serase-1B, a new splice variant of polyserase-1/TMPRSS9, activates urokinase-type plasminogen activator and the proteolytic activation is negatively regulated by glycosaminoglycans.
Okumura Y
,
Hayama M
,
Takahashi E
,
Fujiuchi M
,
Shimabukuro A
,
Yano M
,
Kido H
.
???displayArticle.abstract???
Polyserase-1 (polyserine protease-1)/TMPRSS9 (transmembrane serine protease 9) is a type II transmembrane serine protease (TTSP) that possesses unique three tandem serine protease domains. However, the physiological function of each protease domain remains poorly understood. We discovered a new splice variant of polyserase-1, termed Serase-1B, which contains 34 extra amino acids consisting a SEA module (a domain found in sea urchin sperm protein, enterokinase and agrin) adjacent to the transmembrane domain and the first protease domain with a mucin-like box at the C-terminus. The tissue distribution of this enzyme by RT (reverse transcription)-PCR analysis revealed high expression in the liver, small intestine, pancreas, testis and peripheral blood CD14+ and CD8+ cells. To investigate the role of Serase-1B, a full-length form recombinant protein was produced. Interestingly, recombinant Serase-1B was partly secreted as a soluble inactive precursor and it was also activated by trypsin. This activated enzyme selectively cleaved synthetic peptides for trypsin and activated protein C, and it was inhibited by several natural serine protease inhibitors, such as aprotinin, alpha2-antiplasmin and plasminogen activator inhibitor 1. In addition, Serase-1B efficiently converted pro-uPA (urokinase-type plasminogen activator) into active uPA and this activation was strongly inhibited by these natural inhibitors. Furthermore, this activation was also negatively regulated by glycosaminoglycans. Our results indicate that Serase-1B is a novel member of TTSPs that might be involved in uPA/plasmin-mediated proteolysis and possibly implicated in biological events such as fibrinolysis and tumour progression.
Bhatt,
Adhesion signaling by a novel mitotic substrate of src kinases.
2005, Pubmed
Bhatt,
Adhesion signaling by a novel mitotic substrate of src kinases.
2005,
Pubmed
Bhatt,
Quantitation of membrane type serine protease 1 (MT-SP1) in transformed and normal cells.
2003,
Pubmed
Cal,
Polyserase-I, a human polyprotease with the ability to generate independent serine protease domains from a single translation product.
2003,
Pubmed
Chan,
Hypertension in mice lacking the proatrial natriuretic peptide convertase corin.
2005,
Pubmed
Cho,
N-terminal processing is essential for release of epithin, a mouse type II membrane serine protease.
2001,
Pubmed
Dahlbäck,
Blood coagulation.
2000,
Pubmed
Hobson,
Mouse DESC1 is located within a cluster of seven DESC1-like genes and encodes a type II transmembrane serine protease that forms serpin inhibitory complexes.
2004,
Pubmed
,
Echinobase
Holzinger,
Mutations in the proenteropeptidase gene are the molecular cause of congenital enteropeptidase deficiency.
2002,
Pubmed
Jacquinet,
Cloning, genomic organization, chromosomal assignment and expression of a novel mosaic serine proteinase: epitheliasin.
2000,
Pubmed
Kim,
Cloning and expression of novel mosaic serine proteases with and without a transmembrane domain from human lung.
2001,
Pubmed
Kim,
Cloning and chromosomal mapping of a gene isolated from thymic stromal cells encoding a new mouse type II membrane serine protease, epithin, containing four LDL receptor modules and two CUB domains.
1999,
Pubmed
Kim,
Filamin is essential for shedding of the transmembrane serine protease, epithin.
2005,
Pubmed
Kitamoto,
cDNA sequence and chromosomal localization of human enterokinase, the proteolytic activator of trypsinogen.
1995,
Pubmed
Laemmli,
Cleavage of structural proteins during the assembly of the head of bacteriophage T4.
1970,
Pubmed
Lang,
Differential expression of a novel serine protease homologue in squamous cell carcinoma of the head and neck.
2001,
Pubmed
Le,
Reverse zymography using fluorogenic substrates for protease inhibitor detection.
2005,
Pubmed
LeMosy,
Activation of a protease cascade involved in patterning the Drosophila embryo.
2001,
Pubmed
Lee,
Activation of hepatocyte growth factor and urokinase/plasminogen activator by matriptase, an epithelial membrane serine protease.
2000,
Pubmed
Leytus,
A novel trypsin-like serine protease (hepsin) with a putative transmembrane domain expressed by human liver and hepatoma cells.
1988,
Pubmed
Lijnen,
Plasmin and matrix metalloproteinases in vascular remodeling.
2001,
Pubmed
Lin,
Molecular cloning of cDNA for matriptase, a matrix-degrading serine protease with trypsin-like activity.
1999,
Pubmed
List,
Matriptase/MT-SP1 is required for postnatal survival, epidermal barrier function, hair follicle development, and thymic homeostasis.
2002,
Pubmed
List,
Loss of proteolytically processed filaggrin caused by epidermal deletion of Matriptase/MT-SP1.
2003,
Pubmed
Murakami,
Mini-plasmin found in the epithelial cells of bronchioles triggers infection by broad-spectrum influenza A viruses and Sendai virus.
2001,
Pubmed
Netzel-Arnett,
Membrane anchored serine proteases: a rapidly expanding group of cell surface proteolytic enzymes with potential roles in cancer.
2003,
Pubmed
Paoloni-Giacobino,
Cloning of the TMPRSS2 gene, which encodes a novel serine protease with transmembrane, LDLRA, and SRCR domains and maps to 21q22.3.
1997,
Pubmed
Rezaie,
Identification of basic residues in the heparin-binding exosite of factor Xa critical for heparin and factor Va binding.
2000,
Pubmed
Scott,
Insertion of beta-satellite repeats identifies a transmembrane protease causing both congenital and childhood onset autosomal recessive deafness.
2001,
Pubmed
Sheehan,
Molecular mapping of the heparin-binding exosite of thrombin.
1994,
Pubmed
Shi,
Identification and characterization of a novel matrix-degrading protease from hormone-dependent human breast cancer cells.
1993,
Pubmed
Szabo,
Matriptase-3 is a novel phylogenetically preserved membrane-anchored serine protease with broad serpin reactivity.
2005,
Pubmed
Takeuchi,
Reverse biochemistry: use of macromolecular protease inhibitors to dissect complex biological processes and identify a membrane-type serine protease in epithelial cancer and normal tissue.
1999,
Pubmed
Takeuchi,
Cellular localization of membrane-type serine protease 1 and identification of protease-activated receptor-2 and single-chain urokinase-type plasminogen activator as substrates.
2000,
Pubmed
Tomita,
A novel low-density lipoprotein receptor-related protein with type II membrane protein-like structure is abundant in heart.
1998,
Pubmed
Tsuchiya,
Purification and characterization of a novel membrane-bound arginine-specific serine proteinase from porcine intestinal mucosa.
1994,
Pubmed
Underwood,
Ovarian tumor cells express a novel multi-domain cell surface serine protease.
2000,
Pubmed
Velasco,
Matriptase-2, a membrane-bound mosaic serine proteinase predominantly expressed in human liver and showing degrading activity against extracellular matrix proteins.
2002,
Pubmed
Vu,
Identification and cloning of the membrane-associated serine protease, hepsin, from mouse preimplantation embryos.
1997,
Pubmed
Wallrapp,
A novel transmembrane serine protease (TMPRSS3) overexpressed in pancreatic cancer.
2000,
Pubmed
Wu,
Generation and characterization of mice deficient in hepsin, a hepatic transmembrane serine protease.
1998,
Pubmed
Yamaguchi,
Spinesin/TMPRSS5, a novel transmembrane serine protease, cloned from human spinal cord.
2002,
Pubmed
Yamaoka,
Cloning and characterization of the cDNA for human airway trypsin-like protease.
1998,
Pubmed
Yan,
Corin, a mosaic transmembrane serine protease encoded by a novel cDNA from human heart.
1999,
Pubmed
Yang,
Localization of the heparin binding exosite of factor IXa.
2002,
Pubmed
